Trial site
Rochester
Rochester, Minnesota 55905, United StatesNot linked to an institution yet
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Phase
- Phase 27 trials
- Phase 34 trials
- Phase 12 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Completed5 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- GlaxoSmithKline9 trials
- Tesaro, Inc.6 trials
- ViiV Healthcare1 trial
Running trials
Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
NCT07224672· Phase 2· GlaxoSmithKline· Source
Contact: Shaji Kumar (principal investigator)
Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395· Phase 2· GlaxoSmithKline· Source
Contact: Jonathan Goldstein (principal investigator)
Recruiting
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
NCT06990880· Phase 1/2· GlaxoSmithKline· Source
Contact: Dan Childs (principal investigator)
Active, not recruiting
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
NCT06734234· Phase 1· GlaxoSmithKline· Source
Active, not recruiting
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
NCT06041386· Phase 4· GlaxoSmithKline· Source
Active, not recruiting
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934· Phase 3· GlaxoSmithKline· Source
Active, not recruiting
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
NCT03602859· Phase 3· Tesaro, Inc.· Source
Active, not recruiting
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113· Phase 2· GlaxoSmithKline· Source
Active, not recruiting
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
NCT02655016· Phase 3· Tesaro, Inc.· Source
Active, not recruiting
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
NCT02817633· Phase 1· Tesaro, Inc.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error